Long term side effects of melatonin
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Side Effects of Melatonin: A Comprehensive Review
Introduction to Melatonin and Its Usage
Melatonin, a hormone primarily known for regulating sleep-wake cycles, is widely used both as a prescription medication for sleep disorders and as an over-the-counter supplement. Its applications have expanded beyond sleep aids to include potential benefits in various medical conditions. However, the long-term safety of melatonin remains a topic of concern, especially given its increasing use in diverse populations, including children and individuals with chronic conditions.
Common Adverse Events in Short-Term Use
Short-term use of melatonin is generally considered safe, with most adverse events (AEs) being mild and transient. Commonly reported AEs include daytime sleepiness, headache, dizziness, and hypothermia, which typically resolve without intervention or upon discontinuation of the supplement . These findings are consistent across multiple studies, indicating a favorable safety profile for short-term melatonin use 13.
Long-Term Safety Concerns
General Population
The long-term safety of melatonin, defined as use beyond six months, is less well-documented. A systematic review highlighted the scarcity of robust data from long-term randomized controlled trials (RCTs), cautioning against complacency due to the limited evidence available . While some studies report low frequencies of AEs such as fatigue, mood swings, and somnolence, the overall data are insufficient to draw definitive conclusions about long-term safety 27.
Specific Populations
Children and Adolescents
The use of melatonin in children and adolescents, particularly those with autism spectrum disorder (ASD), has raised specific safety concerns. Long-term studies on pediatric-appropriate prolonged-release melatonin (Ped-PRM) have shown some AEs, including fatigue and mood swings, but no significant effects on growth, pubertal development, or withdrawal symptoms . However, the variability in bioavailability and potential drug interactions necessitate careful monitoring and dose optimization .
Patients with Chronic Conditions
In patients with chronic conditions such as schizophrenia, bipolar disorder, and those undergoing hemodialysis, melatonin's long-term effects have been mixed. For instance, in hemodialysis patients, initial improvements in sleep efficiency and actual sleep time were not sustained over a 12-month period, and no significant improvements in quality of life were observed . Similarly, in patients with severe mental illness tapering off benzodiazepines, melatonin improved self-reported sleep quality but did not affect objective sleep efficiency .
Potential Endocrine and Cardiovascular Effects
Some studies have reported AEs related to endocrine and cardiovascular functions, such as alterations in reproductive parameters, glucose metabolism, blood pressure, and heart rate. These effects appear to be influenced by dosage, timing, and interactions with other medications, particularly antihypertensive drugs . However, these findings are not consistent across all studies, and further research is needed to clarify these potential risks .
Conclusion
While melatonin is generally safe for short-term use, the long-term safety profile remains inadequately studied. The available evidence suggests that most AEs are mild and manageable, but the lack of comprehensive long-term data, especially from high-quality RCTs, limits our understanding of its safety in prolonged use. Future studies should focus on long-term effects, particularly in vulnerable populations, to provide more definitive safety guidelines.
Sources and full results
Most relevant research papers on this topic